• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. INTERCEED* XL (TC7); BARRIER, ABSORBABLE, ADHESION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. INTERCEED* XL (TC7); BARRIER, ABSORBABLE, ADHESION Back to Search Results
Catalog Number 4350XL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anaphylactic Shock (1703); Rash (2033)
Event Date 04/09/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).To date the device has not been returned.If the device or further details are received at the later date a supplemental medwatch will be sent.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.The patient demographic info: age, weight, bmi at the time of index procedure other relevant patient history/concomitant medications? please clarify what does it mean that the patient is not allergic? was allergy testing done? if yes, results? was anything given to the patient prior or during the surgery that could cause anaphylaxis? what intervention was done for anaphylactic shock? was the interceed removed? what is the patient¿s status currently? was the event resolved?.
 
Event Description
It was reported that the patient underwent a hepatectomy procedure on (b)(6) 2019 and the absorbable adhesion barrier was placed on the surface of the liver before closing the surgical wound.During closing the surgical wound, rash was seen on the patient¿s skin, but the wound was closed as it was.After the surgery, anaphylactic shock occurred.The current patient¿s status is stable.The patient is hospitalized currently.It was also reported that causal relationship between the event and the absorbable adhesion barrier is unknown.Additional information has been requested.
 
Manufacturer Narrative
The patient demographic info: age, weight, bmi at the time of index procedure.No further information is available.Other relevant patient history/concomitant medications? no further information is avaialble.Please clarify what does it mean that the patient is not allergic? the patient do not have allergic diathesis.Was allergy testing done? if yes, results? no further information is avaialble.Was anything given to the patient prior or during the surgery that could cause anaphylaxis? no further information is avaialble.What intervention was done for anaphylactic shock? antihistamines and steroids were administered.Was the interceed removed? no.Remain in the patient's body.What is the patient¿s status currently? as of (b)(6) 2019, the patient's condition is stable and there are no plans to extend the hospital stay.Was the event resolved? yes, current status of the patient is stable.No further information will be provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
BARRIER, ABSORBABLE, ADHESION
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
MDR Report Key8589366
MDR Text Key144395996
Report Number2210968-2019-81151
Device Sequence Number1
Product Code MCN
UDI-Device Identifier10705031147843
UDI-Public10705031147843
Combination Product (y/n)N
PMA/PMN Number
P880047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 04/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number4350XL
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/10/2019
Initial Date FDA Received05/07/2019
Supplement Dates Manufacturer Received05/08/2019
Supplement Dates FDA Received05/16/2019
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-